Mesangial Matrix Modulation and Glomerulosclerosis
- 1 April 1999
- journal article
- review article
- Published by S. Karger AG in Nephron Experimental Nephrology
- Vol. 7 (2), 147-159
- https://doi.org/10.1159/000020595
Abstract
Progressive deterioration of the kidney is common to many renal diseases. The structural injuries which lead to this progressive loss of function consist of focal segmental glomerulosclerosis and tubulointerstitial fibrosis and atrophy. These processes were previously thought to be inexorable, regardless of the primary disease. However, recent observations point to the possibility of reversal of sclerosis. Mesangial matrix accumulation is the cornerstone of glomerulosclerosis and results when matrix synthesis exceeds matrix degradation. The renin-angiotensin system appears to be one central component of this process, with links to numerous mechanisms which promote matrix accumulation. Most recently, direct induction of plasminogen activator inhibitor-1 by angiotensin has been recognized. Plasminogen activator inhibitor-1 not only promotes thrombosis, but also inhibits matrix degradation. The various mechanisms which modulate mesangial matrix accumulation and their potential reversibility are reviewed.Keywords
This publication has 35 references indexed in Scilit:
- Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathiesKidney International, 1998
- Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction Rapid CommunicationKidney International, 1998
- Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patientsKidney International, 1998
- Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic SyndromeMolecular Cell, 1998
- Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic GlomerulonephritisThe Journal of Experimental Medicine, 1997
- Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal InsufficiencyNew England Journal of Medicine, 1996
- Transforming Growth Factor-Beta and Angiotensin II: The Missing Link from Glomerular Hyperfiltration to Glomerulosclerosis?Annual Review of Physiology, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Effect of Plasma Protein Adsorption on Protein Excretion in Kidney-Transplant Recipients with Recurrent Nephrotic SyndromeNew England Journal of Medicine, 1994
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990